Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

Metallothionein Mediates the Level and Activity of Nuclear Factor ΚB in Murine Fibroblasts

Heather L. Butcher, Wendy A. Kennette, Olga Collins, Rudolfs K. Zalups and James Koropatnick
Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 589-598; DOI: https://doi.org/10.1124/jpet.104.066126
Heather L. Butcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy A. Kennette
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olga Collins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rudolfs K. Zalups
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Koropatnick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The zinc-binding protein metallothionein (MT) is associated with resistance to apoptosis. We examined whether MT regulates the zinc-dependent antiapoptotic transcription factor nuclear factor ΚB (NF-ΚB), which is up-regulated under many conditions that lead to elevated MT expression. NF-ΚB protein levels and NF-ΚB-dependent reporter gene activity were examined in clonal MT(+) (MT-WT) and MT(–) (MT-KO) fibroblastic cell lines. The amount of cellular NF-ΚB p65 protein in MT-KO was less than 20% of the amount in MT-WT cells, in accord with increased sensitivity of MT-KO cells to apoptosis. NF-ΚB p65 mRNA levels, and NF-ΚB p50 subunit and IΚBα protein levels, were unchanged. NF-ΚB activity assessed by expression of a transfected NF-ΚB reporter construct was less than half that observed in MT-KO cells. Decreased nuclear localization of NF-ΚB p65 in MT-KO clones was not responsible for differences in activity. In fact, MT-KO cells had higher nuclear levels of NF-ΚB p65 than did MT-WT cells, despite a lower cellular NF-ΚB level and function, suggesting that metallothionein mediated the specific activity of NF-ΚB. Reconstitution of MT by stable incorporation of an MT-1 expression vector in MT-KO cells resulted in increased NF-ΚB p65 (but not IΚBα or NF-ΚB p50), increased NF-ΚB-dependent reporter activity, and increased resistance to apoptosis. These data support the hypothesis that metallothionein positively regulates the cellular level and activity of NF-ΚB.

Footnotes

  • This work was supported by grants from the Canadian Institutes of Health Research to J.K. and from the National Institute of Environmental Health Research to R.K.Z. (Grants ES05157 and ES05980) and to R.K.Z. and J.K. (Grant ES11288).

  • DOI: 10.1124/jpet.104.066126.

  • ABBREVIATIONS: MT, metallothionein; NF-ΚB, nuclear factor of the Κ-enhancer in B cells; TNF, tumor necrosis factor; KO, knockout; WT, wild-type; DMEM, Dulbecco's modified Eagle's medium; FBS, fetal bovine serum; bp, base pair(s); GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PBS, phosphate-buffered saline; RT-PCR, reverse transcription-polymerase chain reaction; DTT, dithiothreitol; DELFIA, dissociation-enhanced lanthanide fluoroimmunoassay; TBH, tert-butylhydroperoxide; ANOVA, analysis of variance.

    • Received January 27, 2004.
    • Accepted March 23, 2004.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 310 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 310, Issue 2
1 Aug 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Metallothionein Mediates the Level and Activity of Nuclear Factor ΚB in Murine Fibroblasts
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCELLULAR AND MOLECULAR

Metallothionein Mediates the Level and Activity of Nuclear Factor ΚB in Murine Fibroblasts

Heather L. Butcher, Wendy A. Kennette, Olga Collins, Rudolfs K. Zalups and James Koropatnick
Journal of Pharmacology and Experimental Therapeutics August 1, 2004, 310 (2) 589-598; DOI: https://doi.org/10.1124/jpet.104.066126

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCELLULAR AND MOLECULAR

Metallothionein Mediates the Level and Activity of Nuclear Factor ΚB in Murine Fibroblasts

Heather L. Butcher, Wendy A. Kennette, Olga Collins, Rudolfs K. Zalups and James Koropatnick
Journal of Pharmacology and Experimental Therapeutics August 1, 2004, 310 (2) 589-598; DOI: https://doi.org/10.1124/jpet.104.066126
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Detecting Cancer-Immune Intercellular Interactions
  • Role of ERK1/2 Signaling in Stc2-Mediated Protection
  • Topical arsenicals and transcriptional changes in the kidney
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics